长效β2激动剂的安全性:一点历史。Paul O'Byrne博士采访Roman Jaeschke博士:第一部分。

{"title":"长效β2激动剂的安全性:一点历史。Paul O'Byrne博士采访Roman Jaeschke博士:第一部分。","authors":"P. O'Byrne, R. Jaeschke","doi":"10.20452/pamw.3667","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20343,"journal":{"name":"Polskie Archiwum Medycyny Wewnetrznej","volume":"39 1","pages":"910-911"},"PeriodicalIF":0.0000,"publicationDate":"2016-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety of long-‑acting β2-‑agonists: a little bit of history. Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 1.\",\"authors\":\"P. O'Byrne, R. Jaeschke\",\"doi\":\"10.20452/pamw.3667\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20343,\"journal\":{\"name\":\"Polskie Archiwum Medycyny Wewnetrznej\",\"volume\":\"39 1\",\"pages\":\"910-911\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Polskie Archiwum Medycyny Wewnetrznej\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20452/pamw.3667\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polskie Archiwum Medycyny Wewnetrznej","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20452/pamw.3667","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}